Skip to main content

Advertisement

Log in

The effectiveness and safety of two prophylactic antibiotic regimes in hip-fracture surgery

  • Original Article • HIP - TRAUMA
  • Published:
European Journal of Orthopaedic Surgery & Traumatology Aims and scope Submit manuscript

Abstract

Antibiotic prophylaxis with cefuroxime can reduce the incidence of deep wound infection (DWI) in hip-fracture surgery, but may increase the risk of C. difficile infection (CDI). An alternative is gentamicin with beta-lactam for which a question exists around clinical effectiveness and safety, given the gentamicin-associated nephrotoxicity particularly in the elderly and narrower sensitivity spectrum. We compared 744 consecutive patients (group I—cefuroxime) with 756 in group II (gentamicin + flucloxacillin) who were well matched. There were 4 cases of CDI in the cefuroxime prophylaxis, whereas none in flucloxacillin plus gentamicin (group II). There was a statistically significant (p = 0.036) increased DWI rate in group II (2.5 %) as compared to group I (1.1 %). However, after controlling for age, gender, ASA grade, surgeon grade, implant type and type of anaesthesia, there was no statistically significant difference between the two groups (p = 0.146). 8.5 % of group I and 16.5 % of group II developed AKI post-operatively (p = 0.023); however, 79 % of group I and 80 % of in group II had complete resolution of AKI prior to their discharge. Further, a significant increase in inpatient deaths (p = 0.057) in group II was observed, but not at 30 days (p = 0.378).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Marsh D et al (2007) The care of patients with fragility fractures. British Orthopaedic Association, London

    Google Scholar 

  2. White SM, Griffiths R (2011) Projected incidence of proximal femoral fracture in England: a report from the NHS Hip Fracture Anaesthesia Network (HIPFAN). Injury 42(11):1230–1233

    Article  CAS  PubMed  Google Scholar 

  3. Chesser T et al (2011) The management of hip fracture in adults. National Clinical Guideline Centre, London

    Google Scholar 

  4. Falls Free: Promoting a National Falls Prevention Action Plan: Research Review Papers (2005) NCOA Centre for Healthy Aging, pp 3–18

  5. BOAST 1: Hip fracture in older people, September 2007. http://www.boa.ac.uk. Last accessed 1 Aug 2013

  6. SIGN Guidelines no. 104 “Antibiotics prophylaxis in surgery”—July 2008. http://www.sign.ac.uk/pdf/sign104.pdf. Last accessed 1 Aug 2013

  7. Peel ALG, Taylor EW (1991) Proposed definitions for the audit of postoperative infection: a discussion paper. Ann RCS 73:385–388

    CAS  Google Scholar 

  8. Edwards C, Counsell A, Boulton C, Moran CG (2008) Early infection after hip fracture surgery: risk factors, costs and outcome. J Bone Joint Surg Br 90(6):770–777

    Article  CAS  PubMed  Google Scholar 

  9. Chiu K, Lau S, Fung B, Ng K, Chow S (1993) Plastic adhesive drapes and wound infection after hip fracture surgery. ANZ J Surg 63:798–801

    Article  CAS  Google Scholar 

  10. Mackay DC, Harrison WJ, Bates JHJ, Dickendon D (2000) Audit of deep wound infection following hip fracture surgery. J R Coll Surg Edinb 45:56–59

    CAS  PubMed  Google Scholar 

  11. SIGN Guidelines no. 111“Management of hip fracture in older people”—June 2009

  12. National Clostridium difficile Standards Group (2004) Report to the Department of Health. J Hosp Infect 56:S1–S38

    Google Scholar 

  13. Clostrium difficile infection: how to deal with the problem, London, 2009. http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1232006607827. Last accessed 1 Aug 2013

  14. Dubberke ER, Reske KA, Yan Y et al (2007) Clostridium difficile-associated disease in a setting of endemicity: identification of novel risk factors. Clin Infect Dis 45(12):1543–1549

    Article  PubMed  Google Scholar 

  15. Davey P, Brown E, Fenelon L et al (2006) Systematic review of antimicrobial drug prescribing in hospitals. Emerg Infect Dis 12:211–216

    Article  PubMed  PubMed Central  Google Scholar 

  16. Wilcox MH, Freeman J, Fawley W et al (2004) Long-term surveillance of cefotaxime and piperacillin-tazobactam prescribing and incidence of Clostridium difficile diarrhoea. J Antimicrob Chemother 2004(54):168–172

    Article  Google Scholar 

  17. Kreisel D, Savel TG, Silver AL, Cunningham JD (1995) Surgical antibiotic prophylaxis and Clostridium difficile toxin positivity. Arch Surg 1995(130):989–993

    Article  Google Scholar 

  18. Gilbert DN (2010) Aminoglycosides. In: Mandell GL, Bennett JE, Dolin R (eds) Principle and practice of infectious diseases, 7th edn. Churchill Livingstone, New York, pp 307–336

    Google Scholar 

  19. Starks I, Ayub G, Walley G, Orendi J, Roberts P, Maffulli N (2008) Single-dose cefuroxime with gentamicin reduces Clostridium difficile-associated disease in hip-fracture patients. J Hosp Infect 70(1):21–26

    Article  CAS  PubMed  Google Scholar 

  20. Katzung BG (2001) Basic & clinical pharmacology. 9th Edition, lange medical books, vol 43. McGraw Hill, New York, pp 734–764

  21. Mingeot-Leclerq MP, Tulkens PM (1999) Aminoglycosides: nephrotoxicity. Antimicrob Agents Chemother 43:1003–1012

    Google Scholar 

  22. Rybak MJ, Abate BJ, Kang SL, Ruffing MJ, Lerner SA, Drusano GL (1999) Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity. Antimicrob Agents Chemother 43:1549–1555

    CAS  PubMed  PubMed Central  Google Scholar 

  23. Selby MN, Shaw S, Woodier N, Fluck RJ, Kolhe NV (2009) Gentamicin associated acute kidney injury. Q J Med 102:873–880

    Article  CAS  Google Scholar 

  24. Patterson DL, Robson JM, Wagener MM (1998) Risk factors for toxicity in elderly patients given aminoglycosides once daily. J Gen Intern Med 13:735–739

    Article  Google Scholar 

  25. Raveh D, Kopyt M, Hite Y, Rudensky B, Sonnenblick M, Yinnon AM (2002) Risk factors for nephrotoxicity in elderly patients receiving once-daily aminoglycosides. Q J Med 95:291–297

    Article  CAS  Google Scholar 

  26. Baciewicz AM, Sokos DR, Cowan RI (2003) Aminoglycoside-associated nephrotoxicity in the elderly. Ann Pharm 37:182–186

    CAS  Google Scholar 

  27. Levey AS et al (2005) Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 67:2089–2100

  28. Craig RG, Hunter JM (2008) Recent developments in the perioperative management of adult patients with chronic kidney disease. Br J Anaes 101:296–310

    Article  CAS  Google Scholar 

  29. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG et al (2007) Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11:R31

    Article  PubMed  PubMed Central  Google Scholar 

  30. National Hip Fracture Database National Report (2012) http://www.nhfd.co.uk/. Last accessed 12 Dec 2012

  31. AlBuhairan B, Hind D, Hutchinson A (2008) Antibiotic prophylaxis for wound infections in total joint arthroplasty: a systematic review. J Bone Joint Surg Br 90:915–919

    Article  CAS  PubMed  Google Scholar 

  32. Scottish Antimicrobial Prescription Group: Antibiotic prophylaxis in surgery. http://www.scottishmedicines.org.uk/files/Microsoft_Word_-_SAPG_Guidance_on_surgical_prophylaxis.pdf. Last accessed 1 Aug 2013

  33. Challagundla SR et al (2013) Renal impairment after high-dose flucloxacillin and single-dose gentamicin prophylaxis in patients undergoing elective hip and knee replacement. Nephrol Dial Transpl 28:612–619

    Article  CAS  Google Scholar 

  34. American Academy of Orthopaedic Surgeons. Information statement: recommendations for the use of intravenous antibiotic prophylaxis in primary total joint arthroplasty. http://www.aaos.org/about/papers/advistmt/1027.asp. Last accessed 1 Aug 2013

  35. Slobogean GP, Kennedy SA, Davidson D, O’Brien PJ (2008) Single- versus multiple-dose antibiotic prophylaxis in the surgical treatment of closed fractures: a meta-analysis. J Orthop Trauma 22:264–269

    Article  PubMed  Google Scholar 

  36. Starks I et al (2008) Single-dose cefuroxime with gentamicin reduces Clostridium difficile-associated disease in hip-fracture patients. J Hosp Infect 70:21–26

    Article  CAS  PubMed  Google Scholar 

  37. Jenkins PJ, Teoh K, Simpson PM, Dave J, Simpson AH, Breusch S (2010) Clostridium difficile in patients undergoing primary hip and knee replacement. J Bone Joint Surg Br 92:994–998

    Article  CAS  PubMed  Google Scholar 

  38. Nicolau DP, Freeman CD, Belliveau PP, Nightingale CH, Ross JW, Quintiliani R (1995) Experience with a once-daily aminoglycoside program administered to 2,184 adult patients. Antimicrob Agents Chemother 39:650–655

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Kumin GD (1980) Clinical nephrotoxicity of tobramycin and gentamicin. A prospective study. JAMA 244:1808–1810

    Article  CAS  PubMed  Google Scholar 

  40. Prins JM, Weverling GJ, de Blok K, van Ketel RJ, Speelman P (1996) Validation and nephrotoxicity of a simplified once-daily aminoglycoside dosing schedule and guidelines for monitoring therapy. Antimicrob Agents Chemother 40:2494–2499

    CAS  PubMed  PubMed Central  Google Scholar 

  41. Munckhof WJ, Grayson ML, Turnidge JD (1996) A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided doses. J Antimicrob Chemother 37:645–663

    Article  CAS  PubMed  Google Scholar 

  42. Fujita K, Sayama T, Abe S, Murayama T, Tashiro H (1985) Age dependent aminoglycoside nephrotoxicity. J Urol 134:596–597

    CAS  PubMed  Google Scholar 

  43. Moore RD, Smith CR, Lipski JJ, Mellits ED, Leitman PS (1984) Risk factors for nephrotoxicity in patients treated with aminoglycosides. Ann Intern Med 100:352–357

    Article  CAS  PubMed  Google Scholar 

  44. Roche JJW, Wenn RT, Sahota O, Moran CG (2005) Effect of co-morbidities and postoperative complications on mortality after hip fracture in elderly people: prospective observational cohort study. BMJ 331:1374

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Royal College of Physicians (2007) National clinical audit of falls and bone health in older people. November, 2007. http://old.rcplondon.ac.uk/clinical-standards/ceeu/Documents/fbhop-execsummary.pdf. Accessed 30 July 2013

  46. White SM, Rashid N, Chakladar A (2009) An analysis of renal dysfunction in 1511 patients with fractured neck of femur: the implications for peri-operative analgesia. Anaesthesia 64:1061–1065

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Iftikhar Ahmed.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ahmed, I., Khan, M.A., Allgar, V. et al. The effectiveness and safety of two prophylactic antibiotic regimes in hip-fracture surgery. Eur J Orthop Surg Traumatol 26, 483–492 (2016). https://doi.org/10.1007/s00590-016-1794-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00590-016-1794-7

Keywords

Navigation